Categories: Health

No, you don’t need the ‘Barbie drug’ to tan

Warning: The “Barbie Drug” Melanotan-II is a Recipe for Disaster

TikTok and Instagram influencers have been promoting the “Barbie drug” to help you get a tan, but it’s a recipe for disaster. Melanotan-II, also known as the “sunless tan” drug, is a synthetic version of the hormone α-melanocyte stimulating hormone that stimulates the production of melanin, which promotes skin darkening or tanning.

What is Melanotan-II?

Melanotan-II is a synthetic version of the hormone α-melanocyte stimulating hormone that stimulates the production of melanin, which promotes skin darkening or tanning. It is not registered for use with Australia’s Therapeutic Goods Administration (TGA) and is illegal to advertise or provide without a prescription.

Risks of Melanotan-II

Just like any drug, Melanotan-II comes with risks, including changes in the size and pigmentation of moles, rapid appearance of new moles, flushing to the face, abdominal cramps, nausea, vomiting, chest pain, and brain swelling. It can also cause rhabdomyolysis, a dangerous syndrome where muscle breaks down and releases proteins into the bloodstream that damage the kidneys. For men, it can cause priapism, a painful erection that does not go away and can damage the penis, requiring emergency treatment. Its use has also been linked to melanoma developing from existing moles either during or shortly after using the drug.

Alternatives to Melanotan-II

There are safer ways to get a tanned look. Fake tan is an alternative, but it comes with its own set of risks, including breathing issues and skin inflammation. Embracing your natural skin tone is the best option.

Conclusion

Melanotan-II is a dangerous drug that can have serious side effects, including skin cancer. It is illegal to advertise or provide without a prescription, and its use is not approved by the TGA. There are safer alternatives to getting a tanned look, including fake tan and embracing your natural skin tone. It’s essential to prioritize your health and well-being by avoiding this dangerous drug.

FAQs

Q: What is Melanotan-II?
A: Melanotan-II is a synthetic version of the hormone α-melanocyte stimulating hormone that stimulates the production of melanin, which promotes skin darkening or tanning.

Q: Is Melanotan-II registered for use with the TGA?
A: No, Melanotan-II is not registered for use with the TGA and is illegal to advertise or provide without a prescription.

Q: What are the risks associated with Melanotan-II?
A: The risks associated with Melanotan-II include changes in the size and pigmentation of moles, rapid appearance of new moles, flushing to the face, abdominal cramps, nausea, vomiting, chest pain, and brain swelling. It can also cause rhabdomyolysis, priapism, and melanoma developing from existing moles.

Q: What are the alternatives to Melanotan-II?
A: Safer alternatives to Melanotan-II include fake tan and embracing your natural skin tone.

Fitness Fusion HQ

Recent Posts

Neck Arthritis (Cervical Spondylosis)

Neck Arthritis: Symptoms, Causes, and Treatment Options Symptoms Neck arthritis, also known as neck osteoarthritis…

34 minutes ago

Shaun Clarida’s Back Is a Full Turtle Shell 8 Weeks Out From The 2025 Arnold Classic

The 212 Bodybuilder Shares His Back Training Tricks to Size Up for the Open Division…

5 hours ago

What Happens to Your Body

1. Loaded With Nutrients Milk is a good source of vitamins and minerals. It can…

12 hours ago

Bikini International Competition

Bikini International Champions Nicole Nagrani (2011) Sonia Gonzalez (2012) India Paulino (2013, 2016) Ashley Kaltwasser…

13 hours ago

Shaughna Phillips shows off her dramatic six-stone weight loss transformation in a sizzling bikini after being told she was clinically obese

Shaughna Phillips Flaunts Incredible Weight Loss in Stunning Bikini Snaps Shaughna Phillips, a former Love…

15 hours ago

The Hidden Health Risk of Having Your Hair Washed

Beauty Parlor Stroke Syndrome: A Rare but Serious Health Threat Going to the hairdresser is…

18 hours ago

This website uses cookies.